Last reviewed · How we verify
Oral Aroeira
Oral Aroeira is a small molecule that targets the serotonin receptor.
Oral Aroeira is a small molecule that targets the serotonin receptor. Used for Treatment-resistant depression.
At a glance
| Generic name | Oral Aroeira |
|---|---|
| Sponsor | Infan Industria Quimica Farmaceutica Nacional |
| Drug class | Serotonin receptor antagonist |
| Target | 5-HT2A receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It works by binding to the serotonin receptor, which helps to regulate various physiological processes. This interaction can lead to therapeutic effects in certain conditions.
Approved indications
- Treatment-resistant depression
Common side effects
- Nausea
- Headache
- Dizziness
Key clinical trials
- EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |